Integer Q3 sales +9% to $431M; raises FY outlook; promotes Khales to COO

Integer Holdings Corp

2024-Q3 EPS reported $2.46 revenue$1,267,099,000

Q3 sales $431M (+9% YoY), organic +4%; GAAP op income $58M (+19%), adj op income $76M (+17%).
GAAP diluted EPS $1.01; adj EPS $1.43; adj EBITDA $96M (+18%).
Raises FY 2024 adj op income midpoint to $280-288M (+18-22%); FY sales $1.707-1.727B (+10-11%).
Electrochem divestiture for $50M cash on track to close October 2024.
Khales promoted to COO, Senn to President Cardio & Vascular; both effective Q1 2025.

item 2.02 item 7.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Andrew Senn

President, Cardio and Vascular

ITGR · Integer Holdings Corp

Filed: October 24, 2024, 7:59 PM ET

In connection therewith, Andrew Senn, who currently serves as Senior Vice President, Strategy, Business Development and Investor Relations, has been appointed to serve as President, Cardio and Vascular.

Role change

Payman Khales

Chief Operating Officer

ITGR · Integer Holdings Corp

Filed: October 24, 2024, 7:59 PM ET

On October 24, 2024, the Company announced that Payman Khales, who currently serves as the Company’s President, Cardio & Vascular, has been promoted to serve in the newly created role of Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Senn was appointed as President, Cardio and Vascular at Integer Holdings Corp.

Action: appointed
Role: President, Cardio and Vascular

Exact text from the filing

In connection therewith, Andrew Senn, who currently serves as Senior Vice President, Strategy, Business Development and Investor Relations, has been appointed to serve as President, Cardio and Vascular.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Payman Khales changed role as Chief Operating Officer at Integer Holdings Corp.

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

On October 24, 2024, the Company announced that Payman Khales, who currently serves as the Company’s President, Cardio & Vascular, has been promoted to serve in the newly created role of Chief Operating Officer.

View on SEC.gov

Integer Holdings Corp filing history →

Source: SEC EDGAR

accession 0001171843-24-005802

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.